Is a switch from insulin therapy to liraglutide possible in Japanese type 2 diabetes mellitus patients
The potential of GLP-1 agonists in weight loss has been a topic of ongoing discussion, but FDA approval for obesity has only been granted in the past decade
GLP-1 Companion Nutrition at Vitafoods Europe 2026 Vitafoods Europe 2026, held May 5 to 7 in Barcelona, made GLP-1 companion nutrition one of its defining themes, with dedicated conference sessions and a wave of ingredient launches aimed squarely at the muscle, satiety, and nutrient-adequacy problems above [14, 15]
Lee, S.B., Shin, S., Hepler, J., Gilman, A
Li L, Wang Y, Shen W (2012) Roles of hydrogen sulfide and nitric oxide in the alleviation of cadmium-induced oxidative damage in alfalfa seedling roots
On the flipside, injectable medications are administered once weekly, meaning they could be better for people who may forget to take a once-daily medication